Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort Study

Table 3

Multivariate Cox regression analysis and model fit of the cohort studied (𝑁=416) between 2005 and 2012 in Nekemte Referral Hospital, Ethiopia.

Determinants	Crude HR; (95% CI)	Adjusted HR; (95% CI)
Gender
Male	1.233; (0.602, 2.527 )	1.607; (0.686, 3.762)
Female	1	1
Age
14–40	1	1
≥40	1.977; (0.925, 4.224 )	3.055; (1.292, 7.223)*
Functional status at baseline
Working	1	1
Ambulatory	2.460; (1.129, 5.360)*	1.531; (0.676, 3.470)
Bedridden	10.634; (3.373, 33.520)*	0.891; (0.205, 3.883)
Dependent children at home
No	4.013; (1.948, 8.266 )*	1.521; (0.651, 3.554)
Yes	1	1
Baseline hemoglobin level	0.597; (0.431, 0.827)*	0.523; (0.335, 0.816)*
CD4 count category at baseline
CD4 count: >150	6.287; (2.318, 17.051)*	2.940; (0.750, 7.909)
CD4 count: 100–149	4.340; (1.542, 12.217)*	2.049; (0.597, 7.038)
CD4 count: 50–99	1.499; (0.423, 5.314)	0.676; (0.168, 2.724)
CD4 count: <50	1	1
Baseline TLC category
TLC: >1200	8.183; (1.831, 36.576)*	2.656; (0.414, 17.022)
TLC: 600–1200	4.655; (1.397, 15.518)*	3.342; (0.891, 12.535)
TLC: <600	1	1
BMI category
BMI: >18.5	6.426; (2.599, 15.890)*	1.586; (0.540, 4.662)
BMI: 15–18.5	1.553; (0.659, 3.658)	0.954; (0.361, 2.518)
BMI: ≤15	1	1
ART adherence
Poor	52.672; (24.393, 113.735)*	27.848; (8.928, 86.863)*
Good	1	1

Note: *Statistically significant at 𝑃<0.05.